Ünal Hanzade Aybüke, Başarı Ahmet, Özgencil Bahir Kayra, Özgencil Güngör Enver, Erkoç Süheyla Karadağ
Department of Anesthesiology and Reanimation, School of Medicine, Ankara University, 06100 Ankara, Turkey.
Department of Algology, Kayseri City Hospital, 38080 Kayseri, Turkey.
J Clin Med. 2024 Dec 30;14(1):147. doi: 10.3390/jcm14010147.
To compare the efficiency of unilateral and bilateral transforaminal epidural steroid injections (TFESI) in patients with unilateral lumbar disc herniation (LDH). In this prospective randomized single-blinded study, patients with unilateral LDH were randomly divided into two groups: A unilateral TFESI group; and a bilateral TFESI group. The severity of pain and disability were assessed with the Numeric Rating Scale (NRS-11) and Oswestry Disability Index (ODI) at baseline, 1 week, 1 month, and 3 months after interventions. Treatment response was defined as ≥50% reduction in the NRS-11 at the 3-month follow-up. Changes in medication consumption at 3 months following the interventions were recorded. This study protocol is registered at ClinicalTrials.gov (NCT06240793). A total of 104 patients were included in the study (n = 58 in the unilateral TFESI group and n = 46 in the bilateral TFESI group). The NRS-11, ODI scores and medical treatment consumption did not differ statistically between the groups at 3 months ( ˃ 0.05). At 3 months, the rates of patients with a > 50% decrease in NRS-11 scores were 13.8% and 32.6% in the unilateral TFESI group and bilateral TFESI group, respectively. Unilateral and bilateral TFESI both decrease pain severity and disability scores to a similar degree, although bilateral TFESI was more effective in reducing pain severity by over 50% in patients with single-level unilateral LDH.
比较单侧与双侧经椎间孔硬膜外类固醇注射(TFESI)治疗单侧腰椎间盘突出症(LDH)患者的疗效。在这项前瞻性随机单盲研究中,单侧LDH患者被随机分为两组:单侧TFESI组和双侧TFESI组。在干预前基线、干预后1周、1个月和3个月时,采用数字评分量表(NRS-11)和奥斯威斯利功能障碍指数(ODI)评估疼痛和功能障碍的严重程度。治疗反应定义为3个月随访时NRS-11评分降低≥50%。记录干预后3个月时药物消耗的变化。本研究方案已在ClinicalTrials.gov注册(NCT06240793)。共有104例患者纳入研究(单侧TFESI组n = 58例,双侧TFESI组n = 46例)。3个月时,两组间NRS-11、ODI评分及药物治疗消耗无统计学差异(˃ 0.05)。3个月时,单侧TFESI组和双侧TFESI组NRS-11评分降低>50%的患者比例分别为13.8%和32.6%。单侧和双侧TFESI均可使疼痛严重程度和功能障碍评分降低至相似程度,尽管双侧TFESI在降低单节段单侧LDH患者疼痛严重程度方面更有效,疼痛减轻超过50%。